Today: 30 June 2026

Silver price rebound masks fresh stress after CME lifts margins again

Silver price rebound masks fresh stress after CME lifts margins again

New York, Feb 7, 2026, 12:01 EST — Market closed Spot silver staged a sharp turnaround Friday, surging 8.6% to $77.33 an ounce late in the U.S. session after sinking below $65 earlier. Despite the jump, prices were still on track for a weekly slide of more than 8.7%. “What we’re seeing in silver is huge speculation on the long side,” said Jim Wyckoff, senior analyst at Kitco Metals.
7 February 2026
···
Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

New York, Feb 7, 2026, 12:11 — The market has closed. China’s central bank kept up its gold-buying streak for a 15th month in January, bringing reserves to 74.19 million fine troy ounces, worth $369.58 billion, according to official data out Saturday. The yellow metal last traded near $4,960 an ounce—after a wild spike to almost $5,600 in January, then a sharp drop to $4,403.24 on Monday. Despite a 3.75% dip in China’s gold consumption for 2025, down to 950 metric tons, the China Gold Association said purchases of bars and coins soared 35.14%, accounting for over half of demand.
7 February 2026
·
Nvidia stock jumps 8% as AI chip stocks rebound on Big Tech spending — what to watch next week

Nvidia stock jumps 8% as AI chip stocks rebound on Big Tech spending — what to watch next week

New York, Feb 7, 2026, 12:14 EST — Market closed. Nvidia shot up 7.8% on Friday, locking in a strong comeback for AI-linked chip and data center names as traders piled back into “picks-and-shovels” plays. AMD took off with an 8.3% gain, Broadcom rallied 7.1%, and the Philadelphia semiconductor index jumped 5.7%. Amazon, though, dropped 5.6% after warning this year’s capital expenditures would soar over 50%. “There’s real demand” for AI products, said Ross Mayfield, investment strategy analyst at Baird, pointing out that recent selloffs have been quick to attract fresh buyers.
7 February 2026
·······
Dow Jones breaks 50,000 for the first time — here’s what Wall Street watches next

Dow Jones breaks 50,000 for the first time — here’s what Wall Street watches next

New York, February 7, 2026, 12:04 EST — The session has ended. The Dow Jones Industrial Average broke through the 50,000 mark for the first time on Friday, ending the day at 50,115.67 after a surge of 1,206.95 points, or 2.47%. Caterpillar rallied 7.1%, handing the price-weighted index its biggest push as it continued to outperform Wall Street’s broader benchmarks this year. “The Dow is kind of the people’s index,” said Chuck Carlson, CEO of Horizon Investment Services.
7 February 2026
····
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SEOUL, Feb 8, 2026, 01:42 KST — The market has closed. SK hynix slipped 0.36% to close at 839,000 won on Friday, capping a roughly 8% slide for the week. This drop followed S&P Global Ratings’ decision the previous day to lift the company’s long-term credit rating to “BBB+” and assign a positive outlook, citing healthy demand for high-bandwidth memory and stable memory pricing.
7 February 2026
·
Micron stock jumps into the weekend: UBS lifts target to $450 as Nvidia HBM4 doubts surface

Micron stock jumps into the weekend: UBS lifts target to $450 as Nvidia HBM4 doubts surface

New York, Feb 7, 2026, 11:09 — The last bell for the market has rung. Micron Technology, Inc. climbed 3.08% on Friday, finishing the day at $394.69 after ranging between $372.87 and $396.65. With U.S. markets shut, talk is picking up ahead of Monday—some are backing Micron’s AI memory potential, while others question whether it can hold its ground competitively.
7 February 2026
··
1 … 490 491 492 493 494 … 2,124

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Go toTop